PAIA
STJ

Park Avenue Institutional Advisers’s St Jude Medical STJ Stock Holding History

Park Avenue Institutional Advisers’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,791
Closed -$140K – 491
2016
Q2 		$140K Buy
1,791
+10
+0.6% +$713 0.12% 207
2016
Q1 		$98K Sell
1,781
-58
-3% -$3.16K 0.08% 270
2015
Q4 		$114K Sell
1,839
-35
-2% -$2.21K 0.1% 244
2015
Q3 		$118K Sell
1,874
-23
-1% -$1.64K 0.1% 232
2015
Q2 		$139K Buy
+1,897
New +$137K 0.11% 216

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Park Avenue Institutional Advisers's STJ Position: Q3 2016 in Review

Park Avenue Institutional Advisers sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 1,791 shares — an estimated $140K sold.

Park Avenue Institutional Advisers first reported a position in STJ in Q2 2015 and held it in 5 quarters. The position peaked at $140K in Q2 2016. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Park Avenue Institutional Advisers reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 1,791 St Jude Medical shares in Q3 2016, an estimated $140K.
  • Park Avenue Institutional Advisers first reported a position in St Jude Medical in Q2 2015 and held it in 5 quarters.
  • Park Avenue Institutional Advisers's St Jude Medical position peaked at $140K in Q2 2016.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q3 2016, filed 15 Feb 2017.